ZA200600193B - Use of soluble CD164 in inflammatory and/or autoimmune disorders - Google Patents

Use of soluble CD164 in inflammatory and/or autoimmune disorders

Info

Publication number
ZA200600193B
ZA200600193B ZA200600193A ZA200600193A ZA200600193B ZA 200600193 B ZA200600193 B ZA 200600193B ZA 200600193 A ZA200600193 A ZA 200600193A ZA 200600193 A ZA200600193 A ZA 200600193A ZA 200600193 B ZA200600193 B ZA 200600193B
Authority
ZA
South Africa
Prior art keywords
inflammatory
soluble
autoimmune disorders
autoimmune
disorders
Prior art date
Application number
ZA200600193A
Other languages
English (en)
Inventor
Chvatchko Yolande
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ZA200600193B publication Critical patent/ZA200600193B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200600193A 2003-07-23 2004-07-23 Use of soluble CD164 in inflammatory and/or autoimmune disorders ZA200600193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03077316 2003-07-23

Publications (1)

Publication Number Publication Date
ZA200600193B true ZA200600193B (en) 2007-04-25

Family

ID=34112463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200600193A ZA200600193B (en) 2003-07-23 2004-07-23 Use of soluble CD164 in inflammatory and/or autoimmune disorders

Country Status (15)

Country Link
US (2) US20060257402A1 (ko)
EP (1) EP1646396A2 (ko)
JP (1) JP4705028B2 (ko)
KR (1) KR20060106810A (ko)
CN (1) CN1845752A (ko)
AR (1) AR045074A1 (ko)
AU (1) AU2004260835A1 (ko)
BR (1) BRPI0412243A (ko)
CA (1) CA2532870A1 (ko)
EA (1) EA009389B1 (ko)
IL (1) IL173197A0 (ko)
NO (1) NO20060781L (ko)
RS (1) RS20060023A (ko)
WO (1) WO2005011728A2 (ko)
ZA (1) ZA200600193B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803910B2 (en) 2005-01-24 2010-09-28 Merck Serono S.A. Soluble CD164 polypeptides
NZ578077A (en) 2007-02-12 2012-04-27 Stefan Hansson Diagnosis of preeclampsia using free foetal haemoglobin
PT2638915T (pt) * 2008-07-18 2017-01-10 A1M Pharma Ab Utilização médica da alfa 1-microglobulina antioxidante e eliminadora de radicais
US8392585B1 (en) * 2011-09-26 2013-03-05 Theranos, Inc. Methods and systems for facilitating network connectivity
WO2022099695A1 (en) * 2020-11-16 2022-05-19 Jiangsu Cell Tech Medical Research Institute Co., Ltd. Cd164 fusion and uses thereof
CN114891107A (zh) * 2022-05-12 2022-08-12 北京农学院 一种抗猪cd164l2单克隆抗体制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1409536A2 (en) * 2001-02-12 2004-04-21 Curagen Corporation Human proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
RS20060023A (en) 2008-06-05
KR20060106810A (ko) 2006-10-12
US20090285838A1 (en) 2009-11-19
WO2005011728A2 (en) 2005-02-10
EP1646396A2 (en) 2006-04-19
CN1845752A (zh) 2006-10-11
AU2004260835A1 (en) 2005-02-10
CA2532870A1 (en) 2005-02-10
US20060257402A1 (en) 2006-11-16
BRPI0412243A (pt) 2006-09-19
EA200600314A1 (ru) 2006-06-30
AR045074A1 (es) 2005-10-12
JP2006528159A (ja) 2006-12-14
EA009389B1 (ru) 2007-12-28
NO20060781L (no) 2006-03-17
WO2005011728A3 (en) 2005-06-02
JP4705028B2 (ja) 2011-06-22
IL173197A0 (en) 2006-06-11
US8075894B2 (en) 2011-12-13

Similar Documents

Publication Publication Date Title
ZA200600387B (en) Hydrolytically-resistant bornon-containing therapeutics and methods of use
HK1208865A1 (en) Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors 6 pde4
IL172986A0 (en) Hairpin -labeled probes and methods of use
GB2420838B (en) Improvements in tubular bodies and methods of forming same
AU2003247685A8 (en) Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
EP1608318A4 (en) CXCR4 ANTAGONISTS AND METHODS OF USE
EP1802214A4 (en) COMPACT CONTAINER WITH ON-AND-OFF SHIFT STRUCTURE FOR CONTENTS
AU2003259735A8 (en) Small-mer compositions and methods of use
IL181370A0 (en) Non-protein foaming compositions and methods of making the same
EP1735456A4 (en) POYLMERIC COMPOSITIONS AND ASSOCIATED METHODS OF USE
EP1817055A4 (en) ANTI-OVR110 ANTIBODY COMPOSITIONS AND CORRESPONDING METHODS OF USE
EP1691661A4 (en) SOLUBLE TCR MOLECULES AND APPLICATION METHODS
IL177709A0 (en) Caspase inhibitors and uses thereof
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1740120A4 (en) LONG-TERM FORMULATIONS OF NALTREXONE AND METHOD OF USE
EP1674498A4 (en) BLOCK COPOLYMER AND USE THEREOF
ZA200605217B (en) Steel desulphurating agent and use thereof in the desulphuration of steel
IL173197A0 (en) Cd164 derivatives in inflammatory and autoimmune diseaeses
IL169369A0 (en) Thienopyridazinones and their use in modulation of autoimmune disease
HRP20140660T1 (en) Compositions and uses therof
GB0318546D0 (en) Quinoxalinones and their use
AU2003228355A8 (en) Adipocytes and uses thereof
EP1633850A4 (en) OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE
GB0321379D0 (en) Improvements in or relating to caravans and the like